HMG coA-reductase inhibitors (a.k.a. “statins”) are one of the most successful drugs in recent history…one does not have to look far to find good, solid randomized, controlled trials touting the benefits of statin therapy in any number of…
This week’s Lancet has an interesting article from The Indian Polycap Study (TIPS), in which investigators tested the efficacy and tolerability of a single pill containing up to FIVE different cardiovascular medications: a beta-blocker, an ACE-inhibitor, a thiazide…
A recent paper in AJKD by Patel et al describes a curious but well-documented phenomenon: the finding that patients with CKD who are hospitalized with acute coronary syndrome (ACS) are less likely to receive therapies known to be…
I heard a talk today by one of the fellows in our program who is also the senior author on this recent JASN article: Phosphorus Binders and Survival on Dialysis. Interestingly, even though the current KDOQI Guidelines recommend…
Cardiovascular mortality in the general ESRD population is between 10- and 20-fold higher than that of the general population, and is an astounding 65-fold higher in ESRD individuals in the 45-54-year-old subgroup of the Framingham study. A recent…
